What’s the deal with the tension between José Silva and Jacob Hanna over pluripotency? Researchers probing how to reprogram cells into powerful stem cells (induced pluripotent stem cells or IPSCs) and what the molecular mechanisms are behind this process have become entangled in a conflict. Of course over the years scientists including stem cell scientists have …
Silva Comments on MBD3/NuRD Debate with Jacob Hanna Read More »
The STAP cell mess that began in January of this year has in some ways quieted down. In a broader sense, I believe that STAP is now and will be in the future viewed as a scandal that revealed some less than ideal aspects to the world of biomedical science and publishing. Where does this …
STAP Cell Update: STAP-like paper, Real Origin of STAP cells Read More »
By Zubin Master Scientist Yoshiki Sasai, age 52, committed suicide and was found dead on August 5, 2014. Sasai was deputy director of the Center for Developmental Biology (CDB) at RIKEN in Kobe, Japan, and coauthor on two recently retracted Nature papers about a reportedly easier way to make induced pluripotent stem cells. The papers …
I believe that social media has on the whole had a strongly positive impact on the STAP cell situation that the stem cell field has been grappling with for 5 weeks. If the STAP method is proven to be correct at some later date, which is possible, it’s almost certain that those replication efforts will …
Social Media Helps Field Deal With Stressful STAP Stem Cell Situation Read More »
Are the Nature STAP stem cell papers compromised? Could Nature‘s investigation conclude with something as serious as retraction or rather a mild slap on the wrist? Somewhere in between? (note you may find this update post from 2020 to be of interest: Whatever happened to the STAP cell scientists including Haruko Obokata?) Why is this question …
What’s the latest on the now two-week-old STAP stem cell saga? More preliminary data from around the world. People continue to deposit their data into our crowdsourcing page with 8 reports so far and I know some of them are from top-notch labs. Only one of them is even slightly encouraging with a report of …
STAP stem cell update: more prelim data, missing data, & 2011 paper problems Read More »
Is it really deja vu all over again with allegations of potential wrongdoing in a paper on human cloning? “Say it isn’t so!”, is basically the universal reaction I’m getting from people in the stem cell field. Well, sadly it seems to be so folks. What’s going on? Allegations have emerged on a website called …
Human cloning Cell paper under investigation: some perspectives Read More »
One of the more exciting stem cell biotechs out there today is Advanced Cell Technology (ACT). At this time ACT has the only two ES cell-based FDA-approved clinical trials ongoing and so far they have looked quite promising in terms of preliminary safety data. However, ACT has much more in the pipeline including potentially iPS …
Interview with Gary Rabin of Advanced Cell Technology (ACT) Read More »
Many of us in the scientific community who work on cancer got the message below about the extremely dire state of funding. To the NCI-supported scientific community: As you have heard and read, the Budget Control Act (aka “sequestration”) has gone into effect as of March 1st. All components of the NIH, including the …
Official message from Harold Varmus, Director of NCI, on Sequestration Read More »
Businessweek just published a very long, interesting article on Celltex by Susan Berfield yesterday. I was happy to talk with Susan at length about the key issues and be quoted in the article. See image at left of two key Celltex leaders, David Eller, CEO of Celltex, and Stan Jones above (Photograph by Thomas Prior …
Nuggets and pyrite in Businessweek article on Celltex Read More »